Kennedy Capital Management LLC purchased a new stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 99,237 shares of the company’s stock, valued at approximately $2,894,000. Kennedy Capital Management LLC owned 0.42% of OrthoPediatrics at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. CWM LLC lifted its holdings in shares of OrthoPediatrics by 16,283.3% in the 4th quarter. CWM LLC now owns 983 shares of the company’s stock valued at $32,000 after buying an additional 977 shares during the period. International Assets Investment Management LLC increased its position in shares of OrthoPediatrics by 3,151.4% in the fourth quarter. International Assets Investment Management LLC now owns 1,203 shares of the company’s stock valued at $37,000 after buying an additional 1,166 shares in the last quarter. EntryPoint Capital LLC lifted its position in shares of OrthoPediatrics by 56.9% during the 1st quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock valued at $81,000 after buying an additional 1,009 shares in the last quarter. State Board of Administration of Florida Retirement System acquired a new stake in OrthoPediatrics in the 1st quarter worth about $178,000. Finally, Trust Point Inc. purchased a new stake in shares of OrthoPediatrics during the fourth quarter worth approximately $216,000. Institutional investors own 69.05% of the company’s stock.
OrthoPediatrics Trading Down 1.2 %
Shares of NASDAQ:KIDS traded down $0.40 during midday trading on Wednesday, reaching $31.85. 22,691 shares of the company’s stock were exchanged, compared to its average volume of 162,585. The firm’s 50 day simple moving average is $31.36 and its two-hundred day simple moving average is $29.75. OrthoPediatrics Corp. has a fifty-two week low of $23.10 and a fifty-two week high of $42.07. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.45 and a quick ratio of 1.99. The stock has a market cap of $758.99 million, a price-to-earnings ratio of -33.59 and a beta of 1.19.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the stock. JMP Securities reaffirmed a “market outperform” rating and set a $50.00 target price on shares of OrthoPediatrics in a research note on Tuesday, May 7th. Truist Financial reduced their price objective on OrthoPediatrics from $38.00 to $35.00 and set a “hold” rating on the stock in a research report on Tuesday, July 16th. Finally, Needham & Company LLC raised their target price on OrthoPediatrics from $37.00 to $42.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th.
Check Out Our Latest Stock Analysis on KIDS
OrthoPediatrics Profile
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Read More
- Five stocks we like better than OrthoPediatrics
- What Are Dividends? Buy the Best Dividend Stocks
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- Manufacturing Stocks Investing
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- What is a Dividend King?
- 5 Aggressive Growth Stocks for Long-Term Investors
Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report).
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.